Saturday, July 11, 2026

Drug profile · INN

trihexyphenidyl

trihexyphenidyl (ARTANE) is a muscarinic acetylcholine receptor m1 antagonist. Associated with Lacuna Pharma Pty Ltd.

TGA: approved
Patents linked 1
Pipeline programs 1
News articles 0
Drug details — trihexyphenidyl

Quick answer

trihexyphenidyl (ARTANE) is a muscarinic acetylcholine receptor m1 antagonist. Associated with Lacuna Pharma Pty Ltd.

Key facts

INN trihexyphenidyl
Brand ARTANE
Mechanism Muscarinic acetylcholine receptor M1 antagonist

Mechanism of action

Muscarinic acetylcholine receptor M1 antagonist

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. trihexyphenidyl Phase 2 · United Therapeutics Europe · Dystonia
  1. US 11564888

    Extended release compositions comprising trihexyphenidyl

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is trihexyphenidyl?

trihexyphenidyl (ARTANE) is a muscarinic acetylcholine receptor m1 antagonist. Associated with Lacuna Pharma Pty Ltd.

What is the brand name for trihexyphenidyl?

ARTANE is a marketed brand name for trihexyphenidyl. Check FDA Drugs@FDA for the current US label holder and prescribing information.